Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats.

Thakur T, Sharma S, Kumar K, Deshmukh R, Sharma PL.

Eur J Pharmacol. 2013 Aug 15;714(1-3):515-21. doi: 10.1016/j.ejphar.2013.06.035. Epub 2013 Jul 5.

PMID:
23831390
2.

Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.

Bhateja DK, Dhull DK, Gill A, Sidhu A, Sharma S, Reddy BV, Padi SS.

Eur J Pharmacol. 2012 Jan 5;674(1):33-43. doi: 10.1016/j.ejphar.2011.10.029. Epub 2011 Oct 26.

PMID:
22056833
3.
4.

Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.

Kumar P, Padi SS, Naidu PS, Kumar A.

Fundam Clin Pharmacol. 2007 Jun;21(3):297-306.

PMID:
17521299
5.

Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.

Thangarajan S, Deivasigamani A, Natarajan SS, Krishnan P, Mohanan SK.

Int J Neurosci. 2014 Sep;124(9):673-84. doi: 10.3109/00207454.2013.872642. Epub 2014 Jan 23.

PMID:
24325390
7.

Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.

Hariharan A, Shetty S, Shirole T, Jagtap AG.

Neurotoxicology. 2014 Dec;45:139-48. doi: 10.1016/j.neuro.2014.10.004. Epub 2014 Oct 16.

PMID:
25445565
9.

Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.

Kumar P, Kumar A.

Eur J Pharmacol. 2009 Aug 1;615(1-3):91-101. doi: 10.1016/j.ejphar.2009.04.058. Epub 2009 May 13.

PMID:
19445928
11.

Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.

Kumar P, Padi SS, Naidu PS, Kumar A.

Methods Find Exp Clin Pharmacol. 2007 Jan-Feb;29(1):19-25.

PMID:
17344940
13.

Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington's disease in rats.

Shivasharan BD, Nagakannan P, Thippeswamy BS, Veerapur VP, Bansal P, Unnikrishnan MK.

Drug Chem Toxicol. 2013 Oct;36(4):466-73. doi: 10.3109/01480545.2013.776583. Epub 2013 Apr 16.

PMID:
23590827
14.
15.

Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity.

Ahuja M, Bishnoi M, Chopra K.

Toxicology. 2008 Feb 28;244(2-3):111-22. doi: 10.1016/j.tox.2007.11.003. Epub 2007 Nov 13.

PMID:
18164115
16.

Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.

Mehrotra A, Sandhir R.

Behav Brain Res. 2014 Mar 15;261:345-55. doi: 10.1016/j.bbr.2013.12.035. Epub 2014 Jan 3.

PMID:
24393741
17.

Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats.

Sharma V, Bala A, Deshmukh R, Bedi KL, Sharma PL.

Pharmacol Biochem Behav. 2012 Apr;101(2):239-45. doi: 10.1016/j.pbb.2012.01.004. Epub 2012 Jan 20.

PMID:
22285388
18.

Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.

Kumar P, Kalonia H, Kumar A.

Life Sci. 2009 Nov 4;85(19-20):711-8. doi: 10.1016/j.lfs.2009.10.001. Epub 2009 Oct 12.

PMID:
19822156
19.

Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats.

Kumar P, Kumar P, Khan A, Deshmukh R, Lal Sharma P.

Eur J Pharmacol. 2014 Jan 15;723:38-45. doi: 10.1016/j.ejphar.2013.11.036. Epub 2013 Dec 10.

PMID:
24333475
20.

Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.

Kumar P, Kalonia H, Kumar A.

Br J Pharmacol. 2011 Sep;164(2b):644-54. doi: 10.1111/j.1476-5381.2011.01418.x.

Supplemental Content

Support Center